Dividend-adjusted total return · S&P 500 uses VOO · Oct 31, 2023 – Nov 5, 2026RXLS&P 500 · VOO
| Returns | 1D | 1M | 3M | YTD | 1Y | 3Y | 5Y | MAX |
|---|---|---|---|---|---|---|---|---|
| Total return | −4.9% | +19.1% | +23.2% | +36.4% | +54.9% | +89.2% | +43.3% | +1,719.0% |
| Peer average | −11.9% | −28.7% | −25.6% | −9.0% | −7.9% | +100.3% | +41.1% | — |
| S&P 500 · VOO | −4.4% | −5.7% | −4.9% | +8.4% | +9.8% | +82.2% | +71.6% | — |
Key Statistics
Open all fund facts →- AUM
- $119M
- Expense ratio
- 1.08%
- Distribution yield
- 0.9%
- NAV
- $73.64
- Volume
- 28K
- Avg. volume 30D
- 14K
- High today
- $75.69
- Low today
- $69.91
- Previous close
- $73.67
- 52-week high
- $75.69
- 52-week low
- $42.76
- Our risk indicator
- 5/5
RXL in One Breath
RXL Among An Index ETFs
YTDEnd-of-day Nov 6, 2026 · 85 An index ETFs by YTD
$10,000 in RXL
5Y$10,000 in RXL became
$14,327
In the S&P 500 (VOO)
$17,156
Total return, dividends in · Oct 28, 2021 – Nov 5, 2026 · S&P 500 uses VOO
RXL’s Top Holdings
TodayIQMMProshares Genius Mny Mkt Etf12.6%LLY10.0%JNJ5.9%ABBV4.6%MRK3.3%UNH3.2%TMO2.3%AMGN2.3%GILD1.9%ABT1.8%PFE1.5%ISRG1.5%DHR1.3%VRTX1.2%BMY1.2%MDT1.1%MCK1.1%SYK1.0%CVS0.9%MRNAELVREGN48 more
IQMMProshares Genius Mny Mkt Etf12.6%LLY10.0%JNJ5.9%ABBV4.6%MRK3.3%UNH3.2%TMO2.3%AMGN2.3%GILD1.9%ABT1.8%PFEISRG58 more
Drug Manufacturers - GeneralAsset Management - BondsMedical - DiagnosticsMedical - Healthcare PlansMedical - DevicesBiotechnologyOther
ProShares RXL · 70 holdings · tile size = share of the fund · as of Nov 5, 2026
What RXL Holds
TodayDrug Manufacturers - General31.0%
LLY 10.0 · JNJ 5.9 · ABBV 4.6 · MRK 3.3 · AMGN 2.3 · GILD 1.9 · PFE 1.5
Asset Management - Bonds12.6%
IQMM 12.6
Medical - Diagnostics & Research6.7%
TMO 2.3 · DHR 1.3 · IDXX · A · WAT · IQV · MTD
Medical - Healthcare Plans6.5%
UNH 3.2 · CVS · ELV · CI · HUM · CNC
Medical - Devices6.1%
ABT 1.8 · MDT 1.1 · SYK 1.0 · BSX · EW · GEHC · DXCM
Biotechnology3.2%
VRTX 1.2 · MRNA · REGN · INCY · TECH
Other holdings34.0%
ISRG 1.5 · MCK 1.1 · HCA · COR · CAH · BDX · VEEV
ProShares RXL · share of the fund by industry · as of Nov 5, 2026
Proshares’ Share of RXL
Today12.6%
$126 of every $1,000 in RXL is Proshares
Proshares held by RXL
$15.0M
ProShares RXL · each square = $10 of $1,000 · as of Nov 5, 2026
RXL’s Share of An Index ETFs
Today0.1%
of the $138B in 404 An index ETFs
$119M0.1%
$33.2B24.1%
$19.9B14.5%
$84.7B61.4%
An index ETF AUM · Nov 6, 2026
RXL Fee per $100 vs Peers
TodayExpense ratio · An index peers · Nov 6, 2026
Inside RXL
70 holdings · as of Nov 5, 2026RXL
ProShares Ultra Health Care
TodayDrug Manufacturers - General31.0%LLY10.0%JNJ5.9%ABBV4.6%MRK3.3%AMGNGILDPFEBMYAsset Management - Bonds12.6%IQMM12.6%Medical - Diagnostics6.7%TMODHRIDXXAWATIQVILMNLHDGXMedical - Healthcare Plans6.5%UNHCVSELVCIHUMCNCMedical - Devices6.1%ABTMDTSYKBSXEWBiotechnology3.2%VRTXMRNAREGNOther34.0%ISRGMCKHCACORCAHBDX9 more holdings28.1% of the fund
Drug Manufacturers - General31.0%LLY10.0%JNJ5.9%ABBV4.6%MRKAMGNGILD3 moreAsset Management - Bonds12.6%IQMM12.6%Medical - Diagnostics6.7%TMODHRMedical - Healthcare Plans6.5%UNHELVCIMedical - Devices6.1%ABTMDTSYKBSXEWBiotechnology3.2%VRTXMRNAOther34.0%ISRGMCKHCACORCAHBDX12 more holdings29.1% of the fund
| # | Ticker | Company | Weight ▼ |
|---|---|---|---|
| 1 | IQMM | Proshares Genius MNY MKT ETF | 12.58% |
| 2 | LLY | ELI Lilly & | 10.01% |
| 3 | JNJ | Johnson & Johnson | 5.88% |
| 4 | ABBV | Abbvie | 4.60% |
| 5 | MRK | Merck & | 3.27% |
| 6 | UNH | Unitedhealth Group | 3.24% |
| 7 | TMO | Thermo Fisher Scientific | 2.30% |
| 8 | AMGN | Amgen | 2.28% |
| 9 | GILD | Gilead Sciences | 1.91% |
| 10 | ABT | Abbott Laboratories | 1.76% |
Drug Manufacturers - GeneralAsset Management - BondsMedical - DiagnosticsMedical - Healthcare PlansMedical - DevicesBiotechnologyOther
ProShares RXL · current holdings by weight · as of Nov 5, 2026 · each tile is one holding · top 20 = 59.6%
All RXL Holdings
68 holdings · as of Nov 5, 2026 →RXL
RXL’s Holdings
Top 15 by weight| # | Per $1,000 | |||||
|---|---|---|---|---|---|---|
| 1 | —Net Other Assets (Liabilities) | — | 26.84% | $268.35 | 32.0M | $32.0M |
| 2 | IQMMProshares Genius MNY MKT ETF | Financial Services | 12.58% | $125.85 | 150K | $15.0M |
| 3 | LLYELI Lilly | Healthcare | 10.01% | $100.13 | 8,424 | $11.9M |
| 4 | JNJJohnson & Johnson | Healthcare | 5.88% | $58.77 | 25K | $7.0M |
| 5 | ABBVAbbvie | Healthcare | 4.60% | $45.98 | 19K | $5.5M |
| 6 | MRKMerck | Healthcare | 3.27% | $32.74 | 26K | $3.9M |
| 7 | UNHUnitedhealth Group | Healthcare | 3.24% | $32.43 | 9,450 | $3.9M |
| 8 | TMOThermo Fisher Scientific | Healthcare | 2.30% | $23.04 | 3,893 | $2.7M |
| 9 | AMGNAmgen | Healthcare | 2.28% | $22.83 | 5,692 | $2.7M |
| 10 | GILDGilead Sciences | Healthcare | 1.91% | $19.09 | 13K | $2.3M |
| 11 | ABTAbbott Laboratories | Healthcare | 1.76% | $17.64 | 18K | $2.1M |
| 12 | PFEPfizer | Healthcare | 1.55% | $15.49 | 60K | $1.8M |
| 13 | ISRGIntuitive Surgical | Healthcare | 1.50% | $15.03 | 3,719 | $1.8M |
| 14 | DHRDanaher | Healthcare | 1.30% | $12.97 | 6,587 | $1.5M |
| 15 | VRTXVertex Pharmaceuticals | Healthcare | 1.23% | $12.28 | 2,669 | $1.5M |
ProShares RXL · per $ = dollars of each holding in that stake · as of Nov 5, 2026
How It Compares
RXL
ProShares Ultra Health Care’s Peers
YTDAn index peers · YTD and past-year returns · as of Nov 6, 2026 · sorted by AUM
Head to Head
Put RXL head to head with QLD →QLD vs RXL
YTDYear to date
RXL wins+33.6 pts
Past year
RXL wins+54.8 pts
Fee
QLD winslower fee
Yield
RXL wins+0.7 pts
AUM
QLD107.0× more
3–1RXL wins
ProShares QLD and ProShares RXL · year-to-date · as of Nov 6, 2026 · AUM not scored
RXL vs VOO
YTDRXL · ProShares Ultra Health Care
+36.4%
VOO · S&P 500
+8.4%
Gap
28.0 pts
ProShares RXL and Vanguard VOO · YTD total return · as of Nov 6, 2026
RXL vs Its Peer Average
YTDRXLAvsBPeer average
1D−4.9%−11.9%
1M+19.1%−28.7%
3M+23.2%−25.6%
YTD+36.4%−9.0%
1Y+54.9%−7.9%
3Y+89.2%+100.3%
5Y+43.3%+41.1%
6–1RXL wins
229 An index peers · each row scaled to its leader
The Details
RXL
Risk
1Y5/5our risk indicator
CalmerBumpier
Volatility · 1Y33.65%
Deepest drop · 1Y−21.3%
Lowest point · 5Y−25.6%
52-week range
$70.03
$42.76−7.5% from the high$75.69
ProShares RXL · past-year price moves · as of Nov 6, 2026
RXL
Fund Facts
Today2007launched Jan 30
Tracks[…]
Exchange · CUSIPAMEX · 74347R735
StructureETF
Leverage2x
Cost on $10,000$108 a year
Go deeper
ProShares RXL · fund facts · as of Nov 6, 2026
RXL
Payouts by Year
13Y$0.13per share, Sep 2026
Distribution yield0.9%
PaidEvery quarter
Latest ex-date · paidSep 23 · Sep 29, 2026
12 payouts added up$1.81 a share
ProShares RXL · distributions by ex-date · 2014–2026
All Fund FactsDocuments · trading · fees · every payout
Prospectus & Documents
Trading & Liquidity
Net asset value$73.64
Premium / discount[…]
Median spread · 30D[…]
Volume today28K
Average volume · 30D14K
Shares outstanding[…]
Options[…]
Fees & Costs
Net expense ratio1.08%
Gross expense ratio[…]
Management fee[…]
Cost on $10,000 a year$108.00
Our risk indicator5/5
Estimated yearly cost excludes trading costs and assumes constant assets.
Distributions
| Ex-date | Paid | Per share |
|---|---|---|
| Sep 23, 2026 | Sep 29, 2026 | $0.13 |
| Jun 24, 2026 | Jun 30, 2026 | $0.18 |
| Mar 25, 2026 | Mar 31, 2026 | $0.14 |
| Dec 24, 2025 | Dec 31, 2025 | $0.18 |
| Sep 24, 2025 | Sep 30, 2025 | $0.20 |
| Jun 25, 2025 | Jul 1, 2025 | $0.22 |
| Mar 26, 2025 | Apr 1, 2025 | $0.13 |
| Dec 23, 2024 | Dec 31, 2024 | $0.15 |
| Sep 25, 2024 | Oct 2, 2024 | $0.13 |
| Jun 26, 2024 | Jul 3, 2024 | $0.17 |
| Mar 20, 2024 | Mar 27, 2024 | $0.0860 |
| Dec 20, 2023 | Dec 28, 2023 | $0.0841 |
Issuer contentFrom ProSharesHear the strategy from the people behind RXL.No issuer videos have been published for this fund.Are you the issuer? Claim this fund →